Академический Документы
Профессиональный Документы
Культура Документы
implications those laws have for employers, and recommendations for action
in light of the new reality that is medical marijuana.
MEDICAL-MARIJUANA LAWS
Currently, federal law prohibits the use of marijuana for any purpose. In
1970, Congress enacted the Controlled Substances Act (CSA), which divides
illicit and prescription drugs into five levels, or “schedules.”1 Each schedule
contains its own set of restrictions and allowances based on the federal gov-
ernment’s assessment of each drug’s medicinal properties and potential for
abuse. Under the CSA, marijuana is a Schedule I drug, meaning it has no
recognized medical purpose and cannot be prescribed by physicians. Anyone
prescribing, using, cultivating, or possessing marijuana can be punished
under federal law. Because federal law preempts conflicting state law, this is
true even in those states that have enacted statutes permitting the use of
marijuana for medical purposes.
Practically speaking, however, it has become rare for federal authorities
to pursue prosecution of medical-marijuana users. In October 2009, the U.S.
Department of Justice issued formal guidelines to federal prosecutors
encouraging them to stop focusing enforcement efforts and expending fed-
eral resources on medical-marijuana users and caregivers who comply with
relevant state laws.2 Effectively, DOJ’s decision has largely left the issue of
the legality of medical-marijuana usage in the hands of the states.
Although the majority of states do not recognize marijuana as having
medicinal value and do not protect users from state prosecution, 14 states
have enacted laws that protect from state prosecution persons who pre-
scribe, possess, cultivate, or use marijuana for medical reasons: Alaska, Cali-
fornia, Colorado, Hawaii, Maine, Michigan, Montana, Nevada, New Jersey,
New Mexico, Oregon, Rhode Island, Vermont, and Washington.3
The two most common requirements for coverage under existing medical-
marijuana statutes are (1) diagnosis of a qualifying debilitating illness and
(2) registration with the state. The definitions of “debilitating” illness or
Even in the states that permit the use of medical marijuana, the rights of use
and possession granted to qualified patients are not unlimited. In general,
these states have established restrictions and limits relating to the use of
medical marijuana that fall into three categories: (1) the places marijuana
may not be used; (2) the amount of marijuana a qualified patient may pos-
sess; and (3) health insurance reimbursement for the cost of medical mari-
juana.
The four most common places that marijuana use is limited are public
spaces, correctional facilities, schools, and places of employment. All states
with medical-marijuana laws prohibit or limit in some way the use of mari-
juana in public places. Rhode Island, Hawaii, Maine, Michigan, New Mex-
ico, and Washington restrict the use of marijuana in any public place.10 Col-
orado, Nevada, and Oregon apply the restriction to include any place in
plain view of the general public.11 Other states prohibit marijuana use only
in specified public areas. California, for example, prohibits the use of mari-
juana in any place where smoking is prohibited or within 1,000 feet of a
recreation or youth center, unless within a place of residence.12 Similarly,
Alaska prohibits marijuana usage on or within 500 feet of recreation or
youth centers. Montana and Vermont restrict the use of marijuana in public
parks, public beaches, public recreation centers, and youth centers. New Jer-
sey bans marijuana usage from public parks, public beaches, recreation cen-
ters, and any place smoking is prohibited pursuant to New Jersey law.
With the exception of Colorado, Hawaii, and New Mexico, every state
with a medical-marijuana law restricts the use of marijuana in correctional
facilities. The use of marijuana on or near school grounds is prohibited in
every state with a medical-marijuana law except Colorado, Nevada, and Ore-
gon.13 Most states also expressly prohibit medical-marijuana usage on school
buses and in motor vehicles while they are being operated.14
Possession Limits
The critical question in states that permit the use of marijuana for medical
purposes is how far must employers go to accommodate such use. Because
many of these statutes are only recently enacted, few courts have addressed
the application of these laws in the employment context. However, as dis-
cussed in this section, the developing case law is decidedly pro-employer.
In considering the interplay between state laws addressing medical-
marijuana usage and employers’ obligations to their employees who use
medical marijuana, it is helpful to divide potential issues into two cate-
gories: (1) the protected status, if any, of employees who are qualified
patients and (2) accommodation of the use of medical marijuana by employ-
ees. This section discusses both of these issues and concludes with recom-
mendations to employers in light of recent case decisions.
The most obvious question that employers will ask regarding the medical-
marijuana issue is this: Can I lawfully terminate or refuse to hire someone
solely because they use medical marijuana? The brief answer to the question
is this: In California, Oregon, Montana, and Washington, the courts have
ruled that employers may terminate employees because they are using medi-
cal marijuana. In contrast, statutes in Maine and Rhode Island forbid
employers from refusing to employ individuals based on their status as a
qualified patient.19 In the remaining states, the answer is less clear. These
answers are explained in more detail in the paragraphs that follow.
Recommended Actions
CONCLUSION
Although the federal government and the majority of states currently ban all
use, possession, and cultivation of marijuana, a growing number of states
have adopted laws providing some protection for individuals who use mari-
juana for medical purposes. No state currently requires that employers
accommodate the use of marijuana in the workplace, and only Maine and
Rhode Island protect employees from termination based on their status as
registered users of medical marijuana. But the future is still hazy, and with
many states considering passage of medical-marijuana laws, employers are
well advised to review their policies on drug testing and accommodation
and to stay alert for coming developments regarding employees’ rights to
use medical marijuana.
NOTES
Medical Marijuana Act, Mont. Code Ann. §§ 50-46-101 to 210 (2004); Nev. Rev. Stat. §§ 453A.010 to
.810 (2001); New Jersey Compassionate Use Medical Marijuana Act, N.J. Rev. Stat. §§ 24:6I-1 to 16
(2010); Lynn and Erin Compassionate Use Act, N.M. Stat. §§ 26-2B-1 to 7 (2007); Oregon Medical
Marijuana Act, Or. Rev. Stat. §§ 475.300 to .346 (1999); The Edward O. Hawkins and Thomas C.
Slater Medical Marijuana Act, R.I. Gen. Laws §§ 21-28.6-1 to 12 (2005); Vt. Stat. Ann. tit. 18, §§ 4472
to 4474d (2007); and Washington State Medical Use of Marijuana Act, Wash. Rev. Code §§ 69.51A.005
to .902 (1998).
4. Cachexia is a physical wasting syndrome, characterized by weight loss, muscle atrophy, weakness,
and fatigue, that often accompanies chronic diseases.
5. See, e.g., Alaska Stat. § 17.37.070(4).
6. R.I. Gen. Laws § 21-28.6-3; Mich. Comp. Laws § 333.26427(b)(3)(B); N.M. Stat. § 26-2B-5(A)(3)(d);
Wash. Rev. Code § 69.51A.060.
7. Mont. Code Ann. §§ 50-46-102, 103.
8. Cal. Health & Safety Code § 11362.
9. People v. Kelly, 222 P.3d 186, 189 (Cal. 2010).
10. R.I. Gen. Laws § 21-28.6-7; Haw. Rev. Stat. § 329-122(2); Me. Rev. Stat. Ann. tit. 22, §2426(1)(C)(2);
Mich. Comp. Laws § 333.26427(b)(3)(B); N.M. Stat. § 26-2B-5(A)(3)(d); Wash. Rev. Code §
69.51A.060.
11. Colo. Const. art. 18, § 1 (2000); Nev. Rev. Stat. § 453A.300 (2001); Or. Rev. Stat. § 175.316 (1999).
12. Cal. Health & Safety Code § 11362.79.
13. E.g., Vt. Stat. Ann. tit. 18, § 4474c (2007).
14. E.g., Alaska Stat. § 17.37.040 (1998); Cal. Health & Safety Code § 11362.79.
15. Haw. Rev. Stat. § 329-121.
16. E.g., Alaska Stat. § 17.37.040 (limiting possession amount to one ounce of marijuana in usable form
and six marijuana plants, with no more than three mature plants producing usable marijuana at any
one time); Wash. Rev. Code § 246-75-010 (2008) (person allowed to possess six-month supply, defining
statutory six-month supply as meaning no more than twenty-four ounces of usable marijuana and fif-
teen marijuana plants).
17. See People v. Kelly, 222 P.3d 186, 210 (Cal. 2010) (invalidating specific limits set by the state’s Medi-
cal Marijuana Program as inconsistent with the affirmative defense provided under the California
Compassionate Use Act).
18. R.I. Gen. Laws § 21-28.6-7 (2005).
19. Me. Rev. Stat. Ann. tit. 22, § 2423-E (2009); R.I. Gen. Laws § 21-28.6-4.
20. 174 P.3d 200, 205 (Cal. 2008).
21. No. DA 08-0358, 2009 WL 865308, at *2 (Mont. Mar. 31, 2009).
22. 216 P.3d 1055, 1058 (Wash. Ct. App. 2009) (upholding rescission of a conditional offer of employment
to a qualified patient who failed a drug test and holding that the state law authorizing the use of
medical marijuana did not create an implied right of action against employers for wrongful discharge
or an obligation for employers to accommodate an employee’s use of medical marijuana).
23. 230 P.3d 518 (Or. 2010)
24. Despite this decision, it appears that medical-marijuana use remains decriminalized under the Ore-
gon statute. The court noted that the law provides an exemption from state prosecution for use of
medical marijuana in a separate section of the statute. The court stated that its holding was limited to
the statute’s authorization provision and stated: “[W]e do not hold that the Controlled Substances Act
preempts provisions of the Oregon Medical Marijuana Act that exempt the possession, manufacture,
or distribution of medical marijuana from state criminal liability.”
25. Me. Rev. Stat. Ann. tit. 22, § 2423-E (2009); R.I. Gen. Laws § 21-28.6-4 (2005).
26. U.S. Department of Transportation regulations require certain commercial motor vehicle operators to
be tested for alcohol and drugs, and prohibit operators who test positive for certain drugs, including
marijuana, from performing safety-sensitive functions, including operating or repairing a motor vehi-
cle. See 40 C.F.R. 40.1 et seq.; 49 C.F.R. 655.4.
27. The Drug-Free Workplace Act of 1988, Pub. L. No. 200-690, requires businesses with a federal con-
tract worth over $100,000 to meet certain requirements designed to keep the workplace free of illegal
drugs. Specifically, covered contractors must agree to (1) publish a statement and notify employees in
writing that illegal drugs are prohibited in the workplace; (2) publish and notify employees of the
action the contractor will take against violators of the drug-prohibition policy; (3) establish a drug-
free awareness program for employees; (4) notify employees that compliance with the drug prohibi-
tion is a condition of employment, and that employees must notify the contractor of any violation of
federal or state drug abuse statutes occurring in the workplace within five days of conviction;
(5) notify the government contracting agency within 10 days of receipt of an employee conviction
notice; (6) take appropriate personnel action within 30 days of receipt of an employee conviction
notice; (7) require that the convicted employee participate in an approved drug abuse assistance or
rehabilitation program; and (8) make a good-faith effort to maintain a drug-free workplace through
the implementation of these requirements.
28. E.g., Haw. Rev. Stat. § 329-122 (2000); N.M. Stat. § 26-2B-5 (2007); Vt. Stat. Ann. tit. 18, § 4474c
(2010). It should be noted that the New Mexico and Vermont statutes state only that the patient will
not be protected against criminal or civil penalties for the use of marijuana in the workplace.
29. E.g., Alaska Stat. § 17.37.040 (1998).
30. N.J. Rev. Stat. §§ 24:6I-1 (2010).
31. Me. Rev. Stat. Ann. tit. 22, § 2426; R.I. Gen. Laws § 21-28.6-7.
32. R.I. Gen. Laws § 21-28.6-7.
33. See Emerald Steel Fabricators, Inc., 230 P.3d at 518 (upholding termination of qualified patient for
violation of company drug-free workplace policy); Ragingwire Telecomm., Inc., 174 P.3d at 205
(upholding termination of qualified patient who failed a company drug test).